Finance

Lists
Why is 2140 down 2.02%?
Dive Deeper
2140:TADAWUL
AYYAN Investment Co SJSC
SAR 8.26
-2.02%
(-0.17) 1D
Oct 14, 12:30:54 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 2140...
Open
SAR 8.43
High
SAR 8.43
Low
SAR 8.24
Mkt. cap
831.26M
Avg. vol.
378.74K
Volume
166.93K
52-wk high
SAR 14.08
52-wk low
SAR 8.00
EPS
-SAR 1.12
Shares outstanding
100.38M
Open
SAR 8.43
High
SAR 8.43
Low
SAR 8.24
Mkt. cap
831.26M
Avg. vol.
378.74K
Volume
166.93K
52-wk high
SAR 14.08
52-wk low
SAR 8.00
EPS
-SAR 1.12
Shares outstanding
100.38M
News stories
From web sources and news partners
About AYYAN Investment Co SJSC
CEO-
Employees-
FoundedNov 14, 1993
Headquarters-
SectorFood
Websiteayyan.com.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep 2025
Dec 2025
Mar 2026
Mar 2026
Revenue
90.58M
-116.95M
-103.01M
45.59M
Cost of goods sold
2.24M
3.47M
3.10M
2.15M
Cost of revenue
2.24M
3.47M
3.10M
2.15M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.20M
5.73M
4.59M
4.28M
Operating expense
3.20M
5.77M
4.59M
4.28M
Total operating expenses
5.44M
9.24M
7.70M
6.43M
Operating income
85.14M
-126.19M
-110.71M
39.16M
Other non operating income
541.06K
4.01M
2.47K
170.64K
EBT including unusual items
85.66M
-99.57M
37.76M
37.76M
EBT excluding unusual items
85.66M
-121.19M
-116.12M
37.76M
Income tax expense
1.50M
10.01M
5.79M
5.79M
Effective tax rate
1.75%
-10.05%
-2.65%
15.32%
Other operating expenses
-
-
7.83M
-
Net income
84.16M
-109.58M
-119.20M
31.97M
Net profit margin
92.91%
93.69%
70.13%
70.13%
Earnings per share
-
-
-
-
Interest and investment income
-
1.33M
40.18K
-
Interest expense
-16.87K
-338.96K
-5.45M
-1.57M
Net interest expenses
-16.87K
989.08K
-5.41M
-1.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
85.42M
-125.93M
-109.56M
39.42M
Gain or loss from assets sale
-59.13K
1.00
-616.28K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps